- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
18. In Schedule 17—
(a)in the table in Part 2(1) (exemption from the restriction on supply of prescription only medicines), in item 4a, in the words in column 2, omit “for parenteral administration”; and
(b)in the table in Part 5(2) (exemptions from the restrictions in regulations 220 and 221), in item 7a, for the words in column 2 substitute “A medicinal product containing naloxone hydrochloride but no other substance that is classified as a product available only on prescription or as a product available only from a pharmacy.”.
Part 2 was amended by S.I. 2014/490 and 1878, 2015/1503 and 2016/186.
Part 5 was amended by S.I. 2015/1503, 2016/186 and 2018/199.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: